Skip to main content
Premium Trial:

Request an Annual Quote

Dana-Farber Gets $10M for Molecular Imaging Center

NEW YORK (GenomeWeb News) – The Dana-Farber Cancer Institute will use a $10 million grant from the Massachusetts Life Sciences Center to support development of its Molecular Cancer Imaging Facility in South Boston, Mass.

The facility will focus on developing molecular imaging probes and will complement and expand other Dana-Farber cancer therapeutic enterprises in the South Boston area, including the Center for Biomedical Imaging in Oncology, which houses the Lurie Family Imaging Center, the Center for Novel Experimental Therapeutics, and the Profile cancer genomics project. It aims to develop technologies that help physicians diagnose and characterize cancer, select personalized therapies, and monitor the treatment process.

The $10 million grant announced today was awarded under the state's Life Sciences Initiative, a $10-year, $1 billion program that was funded by the state in 2008 and is run by the quasi-public MLSC.

MLSC said that Dana-Farber has committed to making the facility available for use by small businesses that are conducting research within the state.

"Molecular imaging holds tremendous promise for accelerating drug discovery by allowing more rapid assessment of drug efficacy in preclinical and clinical settings," Barrett Rollins, Dana-Farber's chief scientific officer, said in a statement. "Moreover, molecular imaging will play a key role in the delivery of personalized medicine, by allowing clinicians to determine whether specific drugs are effective in days instead of months."

MLSC expects that when the center is operating it will have a staff of 15.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.